Reports for CHEPLAPHARM ARZNEIMITTEL GMBH
Company Name
CHEPLAPHARM ARZNEIMITTEL GMBH
Totals |
||
Shortage reports |
48 |
|
| Actual shortage: | 5 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (2%) | |
| Resolved: | 42 (88%) | |
Discontinuation Reports |
7 |
|
| To be discontinued: | 1 (14%) | |
| Discontinued: | 6 (86%) | |
| Reversed: | 0 (0%) | |
Late reports |
4 (7%) |
|
Overdue reports |
3 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SUPREFACT DEPOT 3 MONTHS | 9.45MG | IMPLANT | Resolved | 2023-10-24 | 2024-05-17 | 207981 |
| ANANDRON | 50MG | TABLET | Resolved | 2023-09-14 | 2024-05-17 | 204346 |
| LOSEC MUPS | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2023-12-13 | 2024-04-26 | 213267 |
| CYTOVENE | 500MG | POWDER FOR SOLUTION | Resolved | 2023-02-14 | 2024-03-14 | 184528 |
| FUNGIZONE | 50MG | POWDER FOR SOLUTION | Actual shortage | 2024-03-08 | 2024-03-12 | 221737 |
| VISUDYNE | 15MG | POWDER FOR SOLUTION | Resolved | 2024-01-04 | 2024-03-01 | 214845 |
| SUPREFACT | 1MG | SOLUTION | Actual shortage | 2024-02-27 | 2024-02-29 | 220741 |
| VALCYTE | 450MG | TABLET | Resolved | 2024-01-04 | 2024-02-01 | 214848 |
| ONE-ALPHA | 2MCG | SOLUTION LIQUID | Actual shortage | 2023-12-13 | 2024-01-22 | 213256 |
| VALCYTE | 450MG | TABLET | Resolved | 2023-09-27 | 2023-11-05 | 205325 |
| VALCYTE | 50MG | POWDER FOR SOLUTION | Resolved | 2023-05-02 | 2023-11-05 | 191497 |
| HYDREA | 500MG | CAPSULE | Resolved | 2023-07-18 | 2023-09-22 | 198947 |
| ONE-ALPHA | 2MCG | DROPS | Resolved | 2023-01-13 | 2023-06-13 | 180961 |
| VALCYTE | 450MG | TABLET | Resolved | 2023-05-02 | 2023-05-25 | 191490 |
| RIVOTRIL | 0.5MG | TABLET | Resolved | 2022-10-12 | 2023-04-01 | 171577 |
| RIVOTRIL | 2MG | TABLET | Resolved | 2022-10-12 | 2023-04-01 | 171580 |
| FUNGIZONE | 50MG | POWDER FOR SOLUTION | Resolved | 2022-11-10 | 2023-02-14 | 174215 |
| ONE-ALPHA | 2MCG | SOLUTION LIQUID | Resolved | 2022-07-18 | 2022-12-16 | 164812 |
| SUPREFACT | 1MG | SOLUTION | Resolved | 2022-09-12 | 2022-12-08 | 169133 |
| INHIBACE PLUS | 12.5MG 5MG | TABLET | Resolved | 2022-08-17 | 2022-09-30 | 166884 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SUPREFACT DEPOT 3 MONTHS | 9.45MG | IMPLANT | Discontinued | 2024-05-16 | 2024-05-17 | 228166 |
| ANANDRON | 50MG | TABLET | Discontinued | 2024-05-16 | 2024-05-17 | 228155 |
| SUPREFACT DEPOT 2 MONTHS | 6.3MG | IMPLANT | To be discontinued | 2024-05-16 | 2024-05-16 | 228169 |
| XELODA | 150MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176355 |
| XELODA | 500MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176359 |
| SUPREFACT | 100MCG | SOLUTION | Discontinued | 2021-12-13 | 2021-12-13 | 151039 |
| LOSEC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-11-19 | 2021-11-19 | 149669 |
Showing 1 to 7 of 7